about
Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.Idiopathic Pulmonary Fibrosis (IPF): An OverviewDrug-Induced Interstitial Lung Disease: A Systematic ReviewNintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experienceBreath biomarkers in idiopathic pulmonary fibrosis: a systematic reviewTreatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art ReviewThe role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review
P50
Q38598382-4894F1F5-EE86-4C3A-8508-8CF4D94183D9Q47110170-AD99BECC-A3D6-4BA9-A1AC-938E89A40E30Q57170607-71019AF7-1612-4DD9-B663-1ED3345376E5Q57463653-EA7D0656-BA5D-45D8-BFB2-49415DF4FD2DQ58698965-0624096A-8297-4F83-9751-196178800353Q60912200-9BDDACA6-F6FF-4065-A89F-02146D88CAFAQ64249095-7CDDFA95-72EB-47F8-A6FB-CF471C6D9606Q92302388-D2483BAD-37A7-4704-B9FD-C5B9FA56F2A4Q92556997-D2FC496B-88AC-4CFC-BCEE-A4C218D45DB5
P50
description
researcher ORCID ID = 0000-0001-8907-0643
@en
wetenschapper
@nl
name
Conal Hayton
@ast
Conal Hayton
@en
Conal Hayton
@es
Conal Hayton
@nl
type
label
Conal Hayton
@ast
Conal Hayton
@en
Conal Hayton
@es
Conal Hayton
@nl
prefLabel
Conal Hayton
@ast
Conal Hayton
@en
Conal Hayton
@es
Conal Hayton
@nl
P1153
55521681800
P31
P496
0000-0001-8907-0643